VENLAFAXINE ALEM XR venlafaxine (as hydrochloride) 75 mg modified release capsule blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

venlafaxine hydrochloride, Quantity: 84.9 mg (Equivalent: venlafaxine, Qty 75 mg)

Disponible desde:

Alembic Pharmaceuticals Australia Pty Ltd

Designación común internacional (DCI):

Venlafaxine hydrochloride

formulario farmacéutico:

Capsule, modified release

Composición:

Excipient Ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; Gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; ethanol absolute; ammonia

Vía de administración:

Oral

Unidades en paquete:

28 capsules

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

VENLAFAXINE ALEM XR is indicated for the treatment of: - Major depression, including prevention of relapse and recurrence where appropriate; - Generalised anxiety disorder; - Social anxiety disorder; Panic disorder, including prevention of relapse.

Resumen del producto:

Visual Identification: Peach opaque cap/ peach opaque body, size '1' hard capsule with thick and thin radial circular bands on both the cap and body in red ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2017-05-17